Conference item : Abstract
Gene therapy for surfactant protein B deficiency using recombinant AAV
- Publication status:
- Published
- Peer review status:
- Reviewed (other)
Actions
Access Document
- Files:
-
-
(Accepted manuscript, 96.4KB)
-
- Publisher copy:
- 10.1016/j.ymthe.2019.04.004
Why is the content I wish to access not available via ORA?
Bibliographic data (the information relating to research outputs) and full-text items (e.g. articles, theses, reports, etc.) arrive in ORA from several different sources. Unfortunately we are not able to make available the full-text for every research output.
Please contact the ORA team (
) if you have queries regarding unavailable content OR if you are aware of a full-text copy we can make available.
) if you have queries regarding unavailable content OR if you are aware of a full-text copy we can make available.
Content may be unavailable for the following four reasons
-
Version unsuitable
-
We have not obtained a suitable full-text for a given research output. See this page for more information.
-
Recently completed
-
Sometimes content is held in ORA but is unavailable for a fixed period of time to comply with the policies and wishes of rights holders.
-
Permissions
-
All content made available in ORA should comply with relevant rights, such as copyright. See this page for more information.
-
Clearance
-
Some thesis volumes scanned as part of the digitisation scheme funded by Dr Leonard Polonsky are currently unavailable due to sensitive material or uncleared third-party copyright content. We are attempting to contact authors whose theses are affected.
Alternative access to the full-text
You may be able to access the full-text directly from the publisher's website using the 'Publisher Copy' link in the 'Links & Downloads' box from a research output's ORA record page. This method may require an institutional or individual subscription to the journal/resource.
Authors
Bibliographic Details
- Publisher:
- Elsevier Publisher's website
- Journal:
- Molecular Therapy Journal website
- Volume:
- 27
- Issue:
- 4-S1
- Pages:
- 250
- Publication date:
- 2019-04-12
- Acceptance date:
- 2019-03-20
- Event title:
- 22nd American Society of Gene and Cell Therapy Annual Meeting (ASGCT 2019)
- Event location:
- Washington D.C., USA
- Event start date:
- 2019-04-29T00:00:00Z
- Event end date:
- 2019-05-02T00:00:00Z
- DOI:
- EISSN:
-
1525-0024
- ISSN:
-
1525-0016
- Source identifiers:
-
1015815
Item Description
- Keywords:
- Subtype:
- Abstract
- Pubs id:
-
pubs:1015815
- UUID:
-
uuid:3bb8c6ae-4fe1-4c0c-abf5-fbb8582b74af
- Local pid:
- pubs:1015815
- Deposit date:
- 2019-06-18
Terms of use
- Copyright holder:
- Meyer-Berg et al.
- Copyright date:
- 2019
- Rights statement:
- © 2019 The Author(s).
- Notes:
- This item is the abstract for a paper presented at the 22nd American Society of Gene and Cell Therapy Annual Meeting (ASGCT 2019), Washington DC, USA, April-May 2019. This is the accepted manuscript version of the abstract, available under a Creative Commons, Attribution, Non-Commercial, No-Derivatives licence. The final version is available online from Elsevier at: https://doi.org/10.1016/j.ymthe.2019.04.004
If you are the owner of this record, you can report an update to it here: Report update to this record